V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20029546 | 20012588 | 1.67 | 87.05 | Adjuvant (A) | 2016-06-08 | 2016-08-11 | FEC + DOCETAXEL | N | N | 20104107 | FEC + DOCETAXEL |
| 20029547 | 20012588 | 1.67 | 66 | Adjuvant (A) | 2014-07-16 | 2014-07-16 | FEC + DOCETAXEL | 02 | N | 20104107 | FEC + DOCETAXEL |
| 20029548 | 20012588 | null | null | Adjuvant (A) | 2015-06-21 | 2015-07-14 | FEC + DOCETAXEL | 2 | null | 20104107 | FEC + DOCETAXEL |
| 20029549 | 20012589 | 1.69 | 56.2 | Adjuvant (A) | null | 2016-06-23 | FEC + DOCETAXEL | N | N | 20104120 | FEC + DOCETAXEL |
| 20029550 | 20012589 | 1.6 | 56.6 | Disease modification (D) | 2016-08-24 | 2016-09-04 | FEC + DOCETAXEL | 02 | N | 20104120 | FEC + DOCETAXEL |
| 20029551 | 20012590 | 1.77 | 82 | Adjuvant (A) | 2016-01-02 | 2016-01-14 | FEC + DOCETAXEL | N | N | 20104134 | FEC + DOCETAXEL |
| 20029552 | 20012590 | 1.55 | 65 | Adjuvant (A) | 2015-12-31 | 2016-01-02 | FEC 100 + DOCETAXEL | 2 | N | 20104134 | FEC + DOCETAXEL |
| 20029553 | 20012591 | 1.72 | 124 | Neo-adjuvant (N) | 2014-05-19 | 2014-05-19 | FEC + DOCETAXEL | 02 | N | 20104137 | FEC + DOCETAXEL |
| 20029554 | 20012591 | 1.75 | 59.9 | Adjuvant (A) | 2014-04-14 | 2014-04-23 | FEC + DOCETAXEL | N | N | 20104137 | FEC + DOCETAXEL |
| 20029555 | 20012592 | null | null | Adjuvant (A) | 2014-01-17 | 2014-01-28 | FEC + DOCETAXEL | N | N | 20104141 | FEC + DOCETAXEL |
| 20029556 | 20012593 | 1.6 | null | Neo-adjuvant (N) | 2013-06-08 | 2013-06-08 | FEC + DOCETAXEL | N | N | 20104146 | FEC + DOCETAXEL |
| 20029557 | 20012594 | 1.54 | 104.3 | Curative (C) | 2015-10-22 | 2015-11-05 | FEC + DOCETAXEL | N | N | 20104147 | FEC + DOCETAXEL |
| 20029558 | 20012595 | 1.7 | 87.3 | Neo-adjuvant (N) | 2013-09-24 | 2013-09-24 | FEC 100 + DOCETAXEL | 02 | N | 20104151 | FEC + DOCETAXEL |
| 20029559 | 20012595 | null | 75.5 | Adjuvant (A) | 2013-11-15 | 2013-11-16 | FEC + DOCETAXEL | 2 | N | 20104151 | FEC + DOCETAXEL |
| 20029560 | 20012596 | 1.63 | 55.5 | Neo-adjuvant (N) | 2015-03-09 | 2015-03-29 | FEC + DOCETAXEL | 02 | N | 20104154 | FEC + DOCETAXEL |
| 20029561 | 20012596 | 1.51 | 89.8 | Adjuvant (A) | 2014-07-05 | 2014-07-05 | FEC + DOCETAXEL | 02 | null | 20104154 | FEC + DOCETAXEL |
| 20029562 | 20012597 | 1.64 | 67.4 | Adjuvant (A) | 2016-06-10 | 2016-06-15 | FEC + DOCETAXEL | 2 | N | 20104157 | FEC + DOCETAXEL |
| 20029563 | 20012597 | 1.5 | 91.7 | Adjuvant (A) | 2015-04-22 | 2015-04-20 | FEC 100 + DOCETAXEL | 2 | null | 20104157 | FEC + DOCETAXEL |
| 20029564 | 20012598 | 1.74 | 65.6 | Adjuvant (A) | null | 2014-08-15 | FEC + DOCETAXEL | N | N | 20104159 | FEC + DOCETAXEL |
| 20029565 | 20012598 | 1.68 | 86.8 | Adjuvant (A) | 2015-04-25 | 2015-05-28 | FEC 100 + DOCETAXEL | N | N | 20104159 | FEC + DOCETAXEL |
| 20029566 | 20012599 | 1.44 | 64.9 | Neo-adjuvant (N) | 2013-06-23 | 2013-07-04 | FEC + DOCETAXEL | 01 | N | 20104161 | FEC + DOCETAXEL |
| 20029567 | 20012600 | null | null | Adjuvant (A) | 2014-12-11 | 2015-01-23 | FEC + DOCETAXEL | N | N | 20104162 | FEC + DOCETAXEL |
| 20029568 | 20012600 | null | null | Adjuvant (A) | 2018-01-14 | 2018-01-21 | FEC 100 + DOCETAXEL | N | N | 20104162 | FEC + DOCETAXEL |
| 20029569 | 20012601 | 1.65 | 83.8 | Adjuvant (A) | 2016-07-07 | 2016-07-07 | CYCLOPHOSPHAMIDE + DOCETAXEL + EPIRUBICIN + FLUOROURACIL | 02 | N | 20104169 | FEC + DOCETAXEL |
| 20029570 | 20012602 | 1.54 | 74 | Curative (C) | 2015-01-27 | 2014-07-22 | FEC + DOCETAXEL | N | N | 20104171 | FEC + DOCETAXEL |
| 20029571 | 20012603 | 1.55 | 58.3 | Adjuvant (A) | 2017-02-02 | 2017-02-04 | FEC 100 + DOCETAXEL | 02 | N | 20104180 | FEC + DOCETAXEL |
| 20029572 | 20012604 | 1.74 | 87.2 | Neo-adjuvant (N) | 2014-04-24 | 2014-07-04 | FEC 100 + DOCETAXEL | 2 | N | 20104181 | FEC + DOCETAXEL |
| 20029573 | 20012604 | 1.73 | 68.6 | Not known (9) | 2016-05-08 | 2016-05-15 | CYCLOPHOSPHAMIDE + DOCETAXEL + EPIRUBICIN + FLUOROURACIL | 02 | N | 20104181 | FEC + DOCETAXEL |
| 20029574 | 20012604 | 1.62 | 91.6 | Neo-adjuvant (N) | 2013-12-23 | 2014-01-07 | FEC 100 + DOCETAXEL | 02 | N | 20104181 | FEC + DOCETAXEL |
| 20029575 | 20012605 | 1.67 | 73 | Adjuvant (A) | 2013-08-08 | 2013-08-18 | FEC + DOCETAXEL | 01 | N | 20104185 | FEC + DOCETAXEL |
| 20029576 | 20012606 | 1.59 | null | Neo-adjuvant (N) | 2013-11-01 | 2013-11-13 | FEC 100 + DOCETAXEL | 02 | N | 20104186 | FEC + DOCETAXEL |
| 20029577 | 20012606 | 1.63 | 62 | Adjuvant (A) | 2014-02-27 | 2014-03-02 | FEC 100 + DOCETAXEL | N | N | 20104186 | FEC + DOCETAXEL |
| 20029578 | 20012607 | null | null | Neo-adjuvant (N) | null | 2013-05-21 | FEC + DOCETAXEL | null | null | 20104190 | FEC + DOCETAXEL |
| 20029579 | 20012607 | 1.58 | 57 | Neo-adjuvant (N) | 2015-10-17 | 2015-11-04 | FEC + DOCETAXEL | 2 | N | 20104190 | FEC + DOCETAXEL |
| 20029580 | 20012608 | 1.62 | 67.4 | null | 2014-02-22 | 2014-03-10 | FEC + DOCETAXEL | N | N | 20104203 | FEC + DOCETAXEL |
| 20029581 | 20012608 | 1.58 | 98.6 | null | 2017-02-22 | 2017-03-09 | FEC + DOCETAXEL | N | N | 20104203 | FEC + DOCETAXEL |
| 20029582 | 20012608 | 1.6 | 78.7 | Adjuvant (A) | 2017-10-01 | 2017-11-25 | FEC 100 + DOCETAXEL | N | N | 20104203 | FEC + DOCETAXEL |
| 20029583 | 20012608 | 1.6 | null | Adjuvant (A) | 2015-02-10 | 2015-03-17 | FEC + DOCETAXEL | 99 | N | 20104203 | FEC + DOCETAXEL |
| 20029584 | 20012608 | 1.63 | 72.7 | Adjuvant (A) | 2016-08-08 | 2016-08-16 | FEC 100 + DOCETAXEL | 02 | null | 20104203 | FEC + DOCETAXEL |
| 20029585 | 20012609 | 1.64 | 70.4 | Neo-adjuvant (N) | 2016-05-18 | 2016-05-27 | FEC 100 + DOCETAXEL | 2 | N | 20104226 | FEC + DOCETAXEL |
| 20029586 | 20012609 | null | null | Neo-adjuvant (N) | 2014-08-15 | 2014-08-17 | FEC 100 + DOCETAXEL | 2 | N | 20104226 | FEC + DOCETAXEL |
| 20029587 | 20012610 | 1.7 | 61.8 | Curative (C) | 2014-06-17 | 2014-06-24 | FEC + DOCETAXEL | 02 | N | 20104238 | FEC + DOCETAXEL |
| 20029588 | 20012610 | 1.64 | null | Adjuvant (A) | 2015-06-06 | 2015-06-20 | FEC + DOCETAXEL | N | N | 20104238 | FEC + DOCETAXEL |
| 20029589 | 20012611 | null | null | Neo-adjuvant (N) | 2015-01-19 | 2015-01-19 | FEC + DOCETAXEL | N | N | 20104246 | FEC + DOCETAXEL |
| 20029590 | 20012611 | 1.59 | 95.9 | Adjuvant (A) | 2017-04-03 | 2017-04-10 | FEC + DOCETAXEL | N | N | 20104246 | FEC + DOCETAXEL |
| 20029591 | 20012612 | 1.64 | 63 | Curative (C) | 2013-11-24 | 2013-11-25 | CYCLOPHOSPHAMIDE + DOCETAXEL + EPIRUBICIN + FLUOROURACIL | 02 | Y | 20104255 | FEC + DOCETAXEL |
| 20029592 | 20012612 | 1.72 | 70.2 | Not known (9) | 2016-11-17 | 2016-12-01 | FEC 100 + DOCETAXEL | 2 | N | 20104255 | FEC + DOCETAXEL |
| 20029593 | 20012613 | 1.74 | 73 | Neo-adjuvant (N) | 2017-09-26 | 2017-09-29 | FEC + DOCETAXEL | 02 | N | 20104261 | FEC + DOCETAXEL |
| 20029594 | 20012613 | 1.57 | 119 | Neo-adjuvant (N) | 2017-04-22 | 2017-04-29 | FEC 100 + DOCETAXEL | N | N | 20104261 | FEC + DOCETAXEL |
| 20029595 | 20012614 | null | null | Adjuvant (A) | 2015-10-30 | 2015-11-16 | FEC + DOCETAXEL | N | N | 20104264 | FEC + DOCETAXEL |